PGY2 SOT Brooke Aston joins us from the University of Cincinnati Medical Center to discuss “Belatacept Maintenance Immunosuppression for Calcineurin Inhibitor Sparing or Avoidance in Pancreas Transplant Recipients With Progressive Renal or Renal Allograft Dysfunction” (Clinical Transplantation, 2025), as well as her residency experience shadowing in the HLA laboratory to gain firsthand insight into transplant immunogenetics and donor-recipient matching.